These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 31417673)

  • 1. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review.
    Zhen X; Lundborg CS; Sun X; Hu X; Dong H
    Antimicrob Resist Infect Control; 2019; 8():137. PubMed ID: 31417673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Burden of Community-Acquired Antibiotic-Resistant Urinary Tract Infections: Systematic Review and Meta-Analysis.
    Zhu NJ; Weldegiorgis M; Carter E; Brown C; Holmes A; Aylin P
    JMIR Public Health Surveill; 2024 Oct; 10():e53828. PubMed ID: 39382601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
    Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
    S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
    Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.
    Mouanga-Ndzime Y; Onanga R; Longo-Pendy NM; Bignoumba M; Bisseye C
    Antimicrob Resist Infect Control; 2023 May; 12(1):47. PubMed ID: 37173760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.
    Mende K; Akers KS; Tyner SD; Bennett JW; Simons MP; Blyth DM; Li P; Stewart L; Tribble DR
    Mil Med; 2022 May; 187(Suppl 2):42-51. PubMed ID: 35512375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
    Hwang H; Kim B
    Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the main MDR pathogens: prevalence and treatment options.
    Esposito S; De Simone G
    Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
    Founou RC; Founou LL; Allam M; Ismail A; Essack SY
    Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.
    Cohen B; Liu J; Larson E
    J Prev Med Hyg; 2017 Dec; 58(4):E294-E301. PubMed ID: 29707660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Modification of Lipopolysaccharide Conferred by
    Liu YY; Chandler CE; Leung LM; McElheny CL; Mettus RT; Shanks RMQ; Liu JH; Goodlett DR; Ernst RK; Doi Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373195
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
    De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
    J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.
    Čivljak R; Giannella M; Di Bella S; Petrosillo N
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):249-64. PubMed ID: 24392752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control.
    Reale M; Strazzulla A; Quirino A; Rizzo C; Marano V; Postorino MC; Mazzitelli M; Greco G; Pisani V; Costa C; Cesana BM; Liberto MC; Torti C; Focà A
    Infez Med; 2017 Jun; 25(2):98-107. PubMed ID: 28603227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis.
    Kingston R; Vella V; Pouwels KB; Schmidt JE; Abdelatif El-Abasiri RA; Reyna-Villasmil E; Hassoun-Kheir N; Harbarth S; Rodríguez-Baño J; Tacconelli E; Arieti F; Gladstone BP; de Kraker MEA; Naylor NR; Robotham JV;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S26-S36. PubMed ID: 38128781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India.
    Kharat AS; Makwana N; Nasser M; Gayen S; Yadav B; Kumar D; Veeraraghavan B; Mercier C
    Int J Antimicrob Agents; 2024 May; 63(5):107125. PubMed ID: 38431109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.